Mark Prygocki Insider Profile
4 Followers
Mark Prygocki, Director at Verrica Pharmaceuticals, holds ― shares in Verrica Pharmaceuticals (Ticker: VRCA), holds 0.00 shares in Revance Therapeutics (Ticker: RVNC), holds 5.77K shares in Clarus Therapeutics Holdings (Ticker: CRXTQ).
Mark Prygocki's Trading History
| CRXTQClarus Therapeutics Holdings | Jun 09, 2022 | ― | Uninformative Buy | ― | $57.66 | |
| RVNCRevance Therapeutics | ― | ― | ― | $0.00 | ||
| VRCAVerrica Pharmaceuticals | ― | Director | ― | ― |
You May Also Like
Mark Prygocki insider profile FAQ
What stocks does Mark Prygocki hold?
Mark Prygocki holds: VRCA, RVNC, CRXTQ stocks.
What is Mark Prygocki's role in Verrica Pharmaceuticals?
Mark Prygocki's role in Verrica Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
